Bevacizumab biosimilar - Pfizer
At a glance
- Drug Originator Pfizer
- Drug Class Antineoplastics; Eye disorder therapies; Immunotherapies; Monoclonal antibodies
- Mechanism of Action Angiogenesis inhibitors; Vascular endothelial growth factor A inhibitors
- USA Patent Applicants PFIZER INC
- USA Patents 1
- BLAs 1
Table of Contents

Disclaimer